SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany · Delayed Price · Currency is EUR 20.20
-0.15 (-0.74%)
At close: Jul 24, 2026
ETR:1SXP Income Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| 992.11 | 986.21 | 957.09 | 180.01 | 821.14 | |
Revenue Growth (YoY) | 1.89% | 3.04% | 431.68% | -78.08% | - |
Cost of Revenue | 665.08 | 653.75 | 634.48 | 50.27 | 524.72 |
Gross Profit | 327.03 | 332.46 | 322.61 | 129.75 | 296.43 |
Selling, General & Admin | 130.63 | 129.88 | 124.48 | 58.08 | 110.21 |
Depreciation & Amortization Expenses | - | - | - | 9.01 | - |
Research & Development | 27.07 | 27.92 | 24.25 | - | 23.53 |
Other Operating Expenses | -10.72 | -12.26 | -6.21 | 40.82 | 11.31 |
Total Operating Expenses | 146.98 | 145.53 | 142.53 | 107.91 | 145.04 |
Operating Income | 194.99 | 200.82 | 192.58 | 21.84 | 164.38 |
Interest Income | 8 | 7.95 | 5.96 | 147.44 | 2.14 |
Interest Expense | -18.39 | -20.01 | -13.49 | -0.04 | -2.69 |
Other Non-Operating Income (Expense) | -0.34 | -1 | -1.08 | -111.45 | -5.54 |
Total Non-Operating Income (Expense) | -10.73 | -13.06 | -8.61 | 35.95 | -6.09 |
Pretax Income | 184.26 | 187.76 | 183.97 | 57.79 | 158.29 |
Provision for Income Taxes | 40.44 | 40.77 | 33.63 | 12.27 | 32.44 |
Net Income | 143.82 | 146.98 | 150.35 | 43.55 | 125.85 |
Minority Interest in Earnings | 0.51 | 0.53 | 0.66 | - | 0.47 |
Net Income to Common | 143.31 | 146.45 | 149.69 | 43.55 | 125.38 |
Net Income Growth | -3.21% | -2.16% | 243.73% | -65.27% | - |
Shares Outstanding (Basic) | 151 | 151 | 151 | 151 | 151 |
Shares Outstanding (Diluted) | 151 | 151 | 151 | 151 | 151 |
Shares Change (YoY) | -0.15% | - | - | - | - |
EPS (Basic) | 0.95 | 0.97 | 0.99 | 1.01 | 0.83 |
EPS (Diluted) | 0.95 | 0.97 | 0.99 | 1.01 | 0.83 |
EPS Growth | -3.06% | -2.02% | -1.98% | 21.69% | - |
Free Cash Flow | 59.04 | 35.6 | 79.69 | 6.19 | 30.11 |
Free Cash Flow Growth | -11.30% | -55.33% | 1188.50% | -79.46% | - |
Free Cash Flow Per Share | 0.39 | 0.24 | 0.53 | 0.04 | 0.20 |
Dividends Per Share | 0.180 | 0.180 | 0.160 | 0.150 | 0.125 |
Dividend Growth | 12.50% | 12.50% | 6.67% | 20.00% | - |
Gross Margin | 32.96% | 33.71% | 33.71% | 72.08% | 36.10% |
Operating Margin | 19.65% | 20.36% | 20.12% | 12.13% | 20.02% |
Profit Margin | 14.50% | 14.90% | 15.71% | 24.19% | 15.33% |
FCF Margin | 5.95% | 3.61% | 8.33% | 3.44% | 3.67% |
EBITDA | 280.09 | 280.26 | 257.55 | 68.48 | 219.73 |
EBITDA Margin | 28.23% | 28.42% | 26.91% | 38.04% | 26.76% |
EBIT | 194.99 | 200.82 | 192.58 | 21.84 | 164.38 |
EBIT Margin | 19.65% | 20.36% | 20.12% | 12.13% | 20.02% |
Effective Tax Rate | 21.95% | 21.72% | 18.28% | 21.24% | 20.49% |